Evaluation of Drug –Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor

This article is protected by copyright. All rights reserved.

Source: Clinical and Translational Science - November 14, 2018 Category: Biomedical Science Authors: Jim J. Xiao, Dorota Nowak, Rodryg Ramlau, Monika Tomaszewska ‐Kiecana, Piotr J. Wysocki, Jeff Isaacson, Jeri Beltman, Eileen Nash, Robert Kaczanowski, Gerhard Arold, Simon Watkins Tags: Article Source Type: research